Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Traitements médicamenteux des métastases cérébrales des cancers du sein HER2+
Breast cancer is the second leading cause of brain metastases. In patients with HER2-positive breast cancer, the incidence of brainmetastases is 40%. Although the arrival of anti-HER2 therapies has meant bette...